HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Are ‘Natural’ Claims Equivalent To ‘All Natural’? Tarte’s $1.7m Settlement Offers Little Instruction

Executive Summary

Tarte admits no wrongdoing in its settlement with nationwide purchasers of its “high performance naturals,” and it put up little fight in order to minimize costs. Insight remains limited as to whether federal courts agree with plaintiffs that general “natural” claims on cosmetic products – as opposed to “all natural” or “100% natural” assertions – mean no synthetic ingredients at all.

You may also be interested in...



Clean Beauty, The New ‘Natural,’ Carries Same Litigation Risk – Attorneys

Beauty and personal-care companies using ‘clean’ labeling and advertising should clearly define the term and ensure consistency across marketing messages, attorneys said at the BBB National Program Inc.’s 18 July webinar, ‘Getting Clean Beauty Advertising Right.’

Plaintiff Puts ‘Clean Beauty’ To Test In Federal Court In Sephora USA Case

The class action complaint in New York federal court suggests a parity between “clean” and natural claims in the understanding of beauty consumers.

Too Small A Company To Interest US Plaintiffs’ Class Action Bar? Think Again, Attorney Says

Locke Lord, LLP senior counsel Sharon Blinkoff shares perspective from her experience defending smaller cosmetics companies against US class action plaintiff demands and litigation.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel